Determination of a new H+—K+ ATPase inhibitor (E3810) and its four metabolites in human plasma by high-performance liquid chromatography
- 3 October 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 660 (1) , 211-220
- https://doi.org/10.1016/0378-4347(94)00270-3
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- New Fluorescent Probes E3810 and Methoxy E3810 for Determining Distributions of the Apical Membrane and the Acidic Compartment of Gastric Acid Secreting Cells.The Japanese Journal of Physiology, 1992
- Effects of the Proton Pump Inhibitor, E3810, on Gastric Secretion and Gastric and Duodenal Ulcers or Erosions in RatsClinical Drug Investigation, 1991
- Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathioneBiochemical Pharmacology, 1991
- The potency of substituted benzimidazoles such as E3810, omeprazole, RO 18-5364 to inhibit gastric H+,K+-ATPase is correlated with the rate of acid-activation of the inhibitorBiochemical Pharmacology, 1990